基本信息来源于合作网站,原文需代理用户跳转至来源网站获取       
摘要:
Background:Network pharmacology was used to explore the mechanism of the Chinese patent medicine Reduning injection in the treatment of corona virus disease 2019.Methods:The chemical constituents and targets of Qinghao(Artemisiae annuae herba),Jinyinhua(Lonicerae japonicae flos),Zhizi(Gardeniae fructus)in the Chinese patent medicine Reduning injection were obtained from Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform,and the target related to corona virus disease 2019 was searched in GeneCards database,then perform Venn analysis on the targets of corona virus disease 2019 and the Chinese patent medicine Reduning injection,to screen the compounds and targets of the Chinese patent medicine Reduning injection in the treatment of corona virus disease 2019.The String platform was used to construct the protein-protein interaction network,and key targets were screened.Cytoscape 3.5.1 was used to construct the active traditional Chinese medicine-chemical composition-target-disease network to screen the key active components,and the gene ontology function and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis were performed on the common target through DAVID(6.8)online analysis data tool to predict the mechanism of action.Results:Fifty-two active ingredients and 232 targets were selected from the Chinese patent medicine Reduning injection,including 44 targets related to corona virus disease 2019.A total of 310 gene ontology biological processes and 94 Kyoto Encyclopedia of Genes and Genomes signaling pathways were obtained,which were mainly involved in inflammation,viral infection,bacterial infection,immune response and substance metabolism,et al.Conclusion:The mechanism of the Chinese patent medicine Reduning injection in the treatment of corona virus disease 2019 may be related to antivirus,bacteriostasis,anti-inflammatory and antifebrile,immune regulation and metabolism regulation,et al.
推荐文章
COVID-19临床资料分析
新型冠状病毒
感染
新型冠状病毒性肺炎
COVID-19疫情下方舱CT的紧急建设
新型冠状病毒肺炎
方舱CT
辐射防护
CT质量控制
儿童COVID-19的流行病学与临床诊疗特点
新型冠状病毒肺炎
儿童
流行病学
诊断治疗
COVID-19合并肺血栓栓塞症的临床特点
新型冠状病毒肺炎
新型冠状病毒
肺栓塞
预后
内容分析
关键词云
关键词热度
相关文献总数  
(/次)
(/年)
文献信息
篇名 Network pharmacology studies on Reduning injection in treatment of COVID-19
来源期刊 亚洲毒理学研究 学科 工学
关键词 Network pharmacology SARS-CoV-2 Reduning injection COVID-19
年,卷(期) 2020,(3) 所属期刊栏目
研究方向 页码范围 85-96
页数 12页 分类号 TP3
字数 语种
DOI
五维指标
传播情况
(/次)
(/年)
引文网络
引文网络
二级参考文献  (0)
共引文献  (0)
参考文献  (0)
节点文献
引证文献  (0)
同被引文献  (0)
二级引证文献  (0)
2020(0)
  • 参考文献(0)
  • 二级参考文献(0)
  • 引证文献(0)
  • 二级引证文献(0)
研究主题发展历程
节点文献
Network
pharmacology
SARS-CoV-2
Reduning
injection
COVID-19
研究起点
研究来源
研究分支
研究去脉
引文网络交叉学科
相关学者/机构
期刊影响力
亚洲毒理学研究
季刊
2703-1583
天津市河东区大直沽中路伯苓大厦B座906
出版文献量(篇)
31
总下载数(次)
0
总被引数(次)
0
论文1v1指导